GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 8,580.00
+140.00 (1.66%)
Oct 29, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 202.92 billion as of October 28, 2026. It is the 22,137th most valuable company in the world and the 799th biggest in South Korea. Its market cap has increased by 14.40% in one year.
Market Cap
202.92B
Enterprise Value
164.65B
Revenue
32.64B
Global Rank
Country Rank
#799 South Korea
PE Ratio
37.34
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 202.92B, a decrease of -22.70%. That is a compound annual growth rate of -16.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 202.92B | 25.81% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 353.05B |
| MEDIPOST | 331.84B |
| SillaJen | 295.81B |
| Genomictree | 238.82B |
| HLB Therapeutics | 234.01B |
| Bioneer | 185.83B |
| GC Cell | 176.27B |
| Helixmith | 175.44B |